HYPR: Hyperfine Inc Price to Sales

Symbol and logo of brand Hyperfine Inc (HYPR)

Patent protection for miniature magnets and FDA certification create stringent barriers to entry for competitors. Hyperfine, Inc. (HYPR) P/S ratio dynamics confirm the impact of these factors, with 3.30 recorded as the baseline value. The growth forecast relies on diversification through AI services and a flawless innovator image established by the Swoop mobile system.

HYPR (Hyperfine) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for Hyperfine Corp (HYPR)

- market price and analyst price targets:
Stock Quotes hyperfine.io|HYPR - Analyst Consensus Forecast
- market capitalization information:
Market Value Hyperfine Corp|HYPR - Enterprise Value
- shareholders' equity book value data:
Equity per Share Hyperfine|HYPR - Book Capitalization|Market Capitalization to Book Value hyperfine.io|HYPR - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Hyperfine, Inc.|HYPR - Long-Term Debt to Capital|Short-Term Debt to Capital Hyperfine Medical|HYPR - Company Debts|Debt to Book Capitalization Ratio Hyperfine Corp|HYPR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Hyperfine|Immediate Liquidity hyperfine.io
- net income and valuation multiples indicators:
HYPR - Company Net Income|Projected Net Profit Hyperfine, Inc.|HYPR - Price to Earnings Ratio|Forward P/E Multiple Hyperfine Inc|HYPR - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Hyperfine Corp|HYPR - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Hyperfine|HYPR - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months hyperfine.io|HYPR - Earnings growth in current year|Expected net earnings per share growth next year Hyperfine, Inc.
- issuer revenue and sales details:
HYPR - Company Revenue|Company Revenue Forecast hyperfine.io|HYPR - Market Cap to Revenue|Price to Expected Revenue Ratio Hyperfine Corp
Fundamental company analysis:hyperfine.io HYPR
Original product of Hyperfine Corp

Hyperfine, Inc. (HYPR) is implementing innovative portable MRI systems, yet slow medical adoption and R&D expenses make revenue the key basis for valuation. By analyzing the company's current P/S ratio, an investor compares the business's market value with actual sales volume to determine the extent to which the market overvalues growth potential relative to current cash flows and recapitalization risks.

Who Hyperfine, Inc. competes with

Market Cap to Revenue abbott.com ABT|P/S Multiple TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Price to Sales|Mettler-Toledo International Inc. - P/S Multiple|WAT (Waters Technologies) - Market Cap to Revenue Ratio|TECH: P/S Multiple|BRKR - Price-to-Revenue Coefficient|AZTA (Azenta) - P/S Multiple|Market Cap to Revenue Varex Imaging Corp (VREX)|P/S Multiple SMLR|P/S Multiple Butterfly Corp (BFLY)|Price-to-Revenue Ratio Mesa Laboratories, Inc. MLAB|quantum-si.com - Price-to-Revenue Ratio|NNOX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio QTRX (Quanterix Corp.)|MASS: P/S Multiple|Price to Sales CapsoVision (CV)|Price-to-Revenue Ratio MaxCyte, Inc.|RPID - Price-to-Revenue Multiple|Market Cap to Revenue SEER (Seer)|P/S Multiple FONAR Corp. (FONR)|P/S Multiple DXR (Daxor)|Price-to-Revenue Coefficient spectral-ai.com (MDAI)|VIVS - Price-to-Revenue Ratio|Price-to-Sales Ratio ACON|akoyabio.com (AKYA) - Price-to-Revenue Ratio|Market Cap to Revenue ThermoGenesis Holdings, Inc.|TLIS (Talis Biomedical Corp.) - P/S Multiple|Price to Sales T2 Biosystems Inc TTOO